These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 4038989)

  • 1. Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors.
    Colotta F; Bersani L; Lazzarin A; Poli G; Mantovani A
    J Immunol; 1985 May; 134(5):3524-31. PubMed ID: 4038989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of tumour necrosis factor in monocyte-mediated rapid killing of actinomycin D-pretreated WEHI 164 sarcoma cells.
    Bersani L; Colotta F; Mantovani A
    Immunology; 1986 Oct; 59(2):323-5. PubMed ID: 3770807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin.
    Kornbluth RS; Edgington TS
    J Immunol; 1986 Oct; 137(8):2585-91. PubMed ID: 3760568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human monocyte-mediated tumor cytotoxicity. I. Demonstration of an oxygen-dependent myeloperoxidase-independent mechanism.
    Mavier P; Edgington TS
    J Immunol; 1984 Apr; 132(4):1980-6. PubMed ID: 6321594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid killing of actinomycin D-treated tumor cells--cytotoxicity of cell-free monocyte supernatants.
    Bersani L; Colotta F; Ghezzi P; Mantovani A
    Immunol Lett; 1985; 11(5-6):351-5. PubMed ID: 4093154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysis of tumor cells by human blood monocytes by a mechanism independent of activation of the oxidative burst.
    Kleinerman ES; Ceccorulli LM; Bonvini E; Zicht R; Gallin JI
    Cancer Res; 1985 May; 45(5):2058-64. PubMed ID: 2985242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide (LPS) stimulates fresh human monocytes to lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumor necrosis factor.
    Chen AR; McKinnon KP; Koren HS
    J Immunol; 1985 Dec; 135(6):3978-87. PubMed ID: 3905966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity.
    Ziegler-Heitbrock HW; Möller A; Linke RP; Haas JG; Rieber EP; Riethmüller G
    Cancer Res; 1986 Nov; 46(11):5947-52. PubMed ID: 3756932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity of activated monocytes on endothelial cells.
    Peri G; Chiaffarino F; Bernasconi S; Padura IM; Mantovani A
    J Immunol; 1990 Feb; 144(4):1444-8. PubMed ID: 2137492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of monocyte cytotoxic factor in cytolysis of actinomycin D-treated WEHI 164 cells mediated by freshly isolated human adherent mononuclear blood cells.
    Austgulen R; Espevik T; Hammerstrøm J; Nissen-Meyer J
    Cancer Res; 1986 Sep; 46(9):4566-70. PubMed ID: 3524816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired oxidative burst does not affect human monocyte tumoricidal activity.
    Chen AR; Koren HS
    J Immunol; 1985 Mar; 134(3):1909-13. PubMed ID: 2981928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-alpha and IFN-gamma can affect both monocytes and tumor cells to modulate monocyte-mediated cytotoxicity.
    Webb DS; Gerrard TL
    J Immunol; 1990 May; 144(9):3643-8. PubMed ID: 2158515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics.
    Bloom ET; Babbitt JT; Kawakami K
    J Immunol; 1986 Jul; 137(1):172-8. PubMed ID: 3711665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes.
    Nissen-Meyer J; Hofsli E; Espevik T; Austgulen R
    Nat Immun Cell Growth Regul; 1988; 7(5-6):266-79. PubMed ID: 3146697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous tumor cell killing by human blood monocytes and human peritoneal macrophages: lack of alteration by endotoxin or quenchers of reactive oxygen species.
    Weinberg JB; Haney AF
    J Natl Cancer Inst; 1983 Jun; 70(6):1005-10. PubMed ID: 6574267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two distinct cytolytic mechanisms of macrophages and monocytes activated by phorbol myristate acetate.
    Chung T; Kim YB
    J Leukoc Biol; 1988 Nov; 44(5):329-36. PubMed ID: 3183511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and initial characterization of tumoricidal monokine(s) from the human monocytic leukemia cell line THP-1.
    Armstrong CA; Klostergaard J; Granger GA
    J Natl Cancer Inst; 1985 Jan; 74(1):1-9. PubMed ID: 3918210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing.
    Martin JH; Edwards SW
    J Immunol; 1993 Apr; 150(8 Pt 1):3478-86. PubMed ID: 8385686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of protease inhibitors on human monocyte IgG Fc receptor II. Evidence that serine esterase activity is essential for Fc gamma RII-mediated binding.
    van de Winkel JG; Jansze M; Capel PJ
    J Immunol; 1990 Sep; 145(6):1890-6. PubMed ID: 2144012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.